Infographic: High-Throughput Generation of Clonal Pharmaceutical Production Cell Lines
Last updated: April 2024
Overview
High-Throughput Nanowell-Based Image-Verified Cloning Technology (HT-NIC) accelerates cell line development (CLD) by providing a rapid and accurate alternative to traditional methods. This advanced technology is crucial in biotechnology for engineering cell lines to produce biologics such as monoclonal antibodies (mAbs), viral vectors, and exosomes.
HT-NIC enables researchers to efficiently screen thousands of clones, identifying stable candidates that yield high quantities of desired molecules, thereby enhancing the overall efficiency and effectiveness of the CLD process.
Establishing a robust and reliable cell line is essential for testing, optimization, and manufacturing of biologics at commercial scale, which is vital for developing new therapeutic molecules.
- Document type: Infographic
- Page count: 1
- Read time: 3 minutes
Key Takeaways
- CLD - how it works
- Challenges of traditional CLD methods
- Advantages of automation
